Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Fixing the Subscription Trap
The FTC’s Negative Option Rule do-over – and what’s at stake.
A Brand Story
Be wary of questionable and deceptive claims in origin stories.
Meta AI Smart Glasses
Mounting lawsuits accuse Meta of breaking privacy promises.
Pizza Hut’s $10 Large Pizza
Breaking down the fine print of this March Madness commercial.
Buffalo Wild Wings’ Pick 6 Meal for Two
Advertised $19.99 price deserves an official review.